For researchers in immunology, inflammation, and rare disease research, choosing the best immunoassays and cell-based assays is critical for generating reliable, high-impact data. Our assays have been now featured in 600+ peer-reviewed scientific publications, demonstrating their role in biomarker discovery, clinical research, and drug development.
With this latest 2024 update to our publication list, you can now explore studies showcasing how our assays support groundbreaking discoveries, from basic research to approved therapies.
For researchers in immunology, inflammation, and rare disease research, choosing the best immunoassays and cell-based assays is critical for generating reliable, high-impact data. Our assays have been now featured in 600+ peer-reviewed scientific publications, demonstrating their role in biomarker discovery, clinical research, and drug development.
With this latest 2024 update to our publication list, you can now explore studies showcasing how our assays support groundbreaking discoveries, from basic research to approved therapies.
In 2024 alone, 38 new publications utilized our complement system assay products, reflecting the growing impact of high-sensitivity immunoassays in translational and clinical research.
We are proud to support researchers in generating high-quality, reproducible data that advances scientific understanding and brings new therapies to patients.
It takes 10–15 years for a new therapeutic to go from discovery to submission for approval.
Every study in these publications represents critical steps in that journey, supporting:
Explore our comprehensive publication database.
Our updated resource allows you to:
We are honored to support researchers working at the cutting edge of immunology, neurology, oncology, and rare disease research.
With 600+ studies and counting, we remain committed to providing the tools and expertise needed to advance life sciences.